Translating molecular science into
bioavailable nutrition.
Solving complex formulation challenges: enhanced cellular uptake, solubility kinetics, and active stabilization.
Formulation Lifecycle
Our 4-phase clinical R&D framework.
Molecular Discovery & Target Identification
Computational modeling to identify synergistic bioactive interactions and optimize ligand affinity before entering bench trials.
Bioavailability Matrix Optimization
Micro-encapsulation, liposomal lipid bilayer creation, or cyclodextrin complexation to protect actives from premature metabolic degradation.
In-Vitro Dissolution & Clinical Assays
Simulated gastric and intestinal fluid testing (USP Dissolution Apparatus) to verify release kinetics, absorption rates, and cellular uptake.
Accelerated Stability & Scaling
ICH-compliant stability chambers (Zone IVb conditions) to prove a 24-36 month shelf life under varying temperature and humidity profiles.
Bioavailability Engineering
Overcoming the gut-blood barrier.
Most active botanicals (such as curcumin, quercetin, and resveratrol) suffer from less than 1-2% baseline bioavailability due to gastric degradation and rapid hepatic first-pass metabolism.
Instrumentation & Rigor
Analytical testing infrastructure.
HPLC & UHPLC-MS/MS
Ultra-high performance liquid chromatography with tandem mass spectrometry for accurate bioactive quantification and contaminant screening.
USP Automated Dissolution Testers
Multi-vessel real-time spectrophotometric dissolution testing to ensure targeted enteric release within narrow GI transit windows.
Particle Size & Zeta Potential Analyzers
Laser diffraction nano-sizing down to 20nm for colloidal emulsions and liposomal suspension stability verification.
Accelerated ICH Stability Chambers
Automated climate-controlled chambers operating at 40°C / 75% RH for stability forecasting and shelf-life certification.